] i , and oxidative stress in cardiomyocytes and PBMCs would complement each other, eliciting similar shifts in gene expression profiles in these tissues demonstrable during the preclinical (week 1) and pathological (week 4) stages of aldosterone/salt treatment (ALDOST).
Background
Inappropriate neurohormonal activation contributes to pathological remodeling of myocardium in HHD associated with aldosteronism. In rats receiving long-term ALDOST, evidence of reparative fibrosis replacing necrotic cardiomyocytes and coronary vasculopathy appears at week 4 associated with the induction of oxidative stress by mitochondria that overwhelms endogenous, largely Zn 2þ -based, antioxidant defenses. Biomarker-guided prediction of risk before the appearance of cardiac pathology would prove invaluable.
Methods
In PBMCs and cardiomyocytes, quantitation of cytoplasmic free Ca 2þ and Zn 2þ , H 2 O 2 , and 8-iosprostane levels and isolation of ribonucleic acid (RNA) and gene expression together with statistical and clustering analyses and confirmation of genes by in situ hybridization and reverse-transcription polymerase chain reaction were performed.
Results
Compared with controls, at weeks 1 and 4 of ALDOST, we found comparable increments in [Ca 2þ ] i , [Zn 2þ ] i , and 8-isoprotane coupled with increased H 2 O 2 production in cardiac mitochondria and PBMCs, together with the common networks of expression profiles dominated by genes involved in oxidative stress, inflammation, and repair. These included 3 central Ingenuity pathway-linked genes: p38 mitogen-activated protein kinase, a stress-responsive protein; nuclear factor-kB, a redox-sensitive transcription factor and a proinflammatory cascade that it regulates; and transforming growth factor-b 1 , a fibrogenic cytokine involved in tissue repair.
Conclusions
Significant overlapping demonstrated in the molecular mimicry of PBMCs and cardiomyocytes during preclinical and pathological stages of ALDOST implies that transcriptional signatures of PBMCs may serve as early noninvasive and novel sentinels predictive of impending pathological remodeling in HHD. The pathophysiological origins of the heart failure associated with hypertensive heart disease (HHD) are rooted in neurohormonal activation that includes circulating effector hormones of the renin-angiotensin-aldosterone system (1, 2) .
It is the endocrine actions of the renin-angiotensinaldosterone system circulating hormones that account for a systemic response the major features of which include a prooxidant phenotype involving diverse tissues, in which the rate of reactive oxygen species generation overwhelms endogenous antioxidant defenses consisting of crucial Zn 2þ -dependent enzymes (3, 4) ; an immunostimulatory state, in which activated circulating lymphocytes and mono cytes (peripheral blood mononuclear cells [PBMCs] ) elaborate proinflammatory cytokines (5) (6) (7) (8) (9) , and a catabolic state with proteolytic degradation of skeletal muscle and elevations in circulating parathyroid hormone (PTH) that account for bone resorption and predispose to fracture (10) (11) (12) (13) (14) (15) . The failing heart likewise undergoes a progressive hormone-mediated structural and biochemical remodeling with ongoing loss of cardiomyocytes.
Biomarkers that, during a preclinical stage, would reveal risk before as well as the presence of cardiac pathology would advance the overall evaluation and management of patients having heart failure with hypertension (16, 17) . We postulated that such biomarkers are likely to originate in pathophysiological events leading to cardiac remodeling. In searching for a surrogate tissue, tracking the pro-oxidant/ proinflammatory pathway to cardiomyocyte necrosis, we turned to PBMCs (lymphocytes and monocytes) as integral to cellular/molecular mechanisms of tissue repair and cardiac pathology (18) . Our rationale in targeting PBMCs as a putative surrogate was based on the following: 1) the gene expression profile of multiple tissues is shared with PBMCs (19); 2) PBMCs are integral to the neuroendocrine-immune system interface invoked during stressor states with the microarray profiling of their transcriptome used to identify molecular signaling pathways; 3) PBMC activation reveals molecular signatures in chronic heart failure and predicts its severity (5-9,20,21); 4) our previous studies identified the activation of the PBMC transcriptome at preclinical (week 1) and pathological (week 4) stages of aldosterone/salt treatment (ALDOST) in rats (22, 23) ; and 5) the availability of PBMCs for clinical interrogation as a noninvasive target that could be monitored serially during the course of neurohormonal activation to predict risk and pathology before and at its appearance and response to intervention. Activated PBMCs during ALDOST express genes associated with oxidative stress, antioxidant defenses, and proinflammatory cytokines implicating, an immunostimulatory state (22, 23) . Cardioprotection, in turn, was assessed by monitoring temporal iterations in cation composition, redox status, and an altered PBMC transcriptome (22) (23) (24) (25) . Hence, these cells lend themselves as potential biomarkers of noninvasive and serial sampling during preclinical and pathological stages of heart failure with hypertension (HHD) and to monitoring cardioprotective strategies (3) (4) (5) (6) (7) (8) (9) 25) . We hypothesized that the pathophysiological changes seen with ALDOST are potentiated by integrated interactions between hormones and divalent cations (i.e., Ca 2þ and Zn 2þ as pro-oxidant and antioxidant), and that these iterations will cause unique and yet similar shifts in gene expression in heart tissue and PBMCs, thus providing characteristic molecular and transcriptional signatures.
Methods
Animal model. Eight-week-old male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, Indiana) were used as previously reported (22, 23 (23, 25) . Isolation of ribonucleic acid (RNA) and gene expression analysis. We isolated RNA using Trizol Reagent (Life Technologies, Carlsbad, California), as previously described (26) . The RNA underwent gene expression analysis using Affymetrix software (Affymetrix Inc., Santa Clara, California), as previously described (22) . This analysis was conducted by the Molecular Resource Center Core Lab at our institution using the GCOS 1.4 software from Affymetrix Inc. We previously reported on the efficacy of our core facility to replicate the relevant expression array data by quantitative reverse-transcription polymerase chain reaction (RT-PCR). Statistical and clustering analysis of gene expression data. Expression data files were uploaded into the GeneSpring DX software (Agilent Technologies, Santa Clara, California) for statistical and cluster analysis, as previously described (27) . Light filtering was initially used to remove those probe sets that were not present in at least 1 of the samples, followed by a 1-way analysis of variance (ANOVA) (p < 0.05) with Benjamini-Hochberg correction for multiple hypothesis testing. Hierarchical clustering of the genes from our ANOVA was carried out to further sort those into subgroups with specific expression patterns, depending on their up-or down-regulation in response to ALDOST. Data mining of gene probe sets identified by the data analysis. The main data mining tool used was Ingenuity Pathways Analysis (Ingenuity Systems, Inc., Redwood City, California), a subscription-based, Web-delivered (www. ingenuity.com) application that allows users to discover, visualize, and explore networks relevant to their experimental results. Our use of this pathway analysis approach was previously described in detail (27) . The pathway analysis not only serves as a tool to gain insights but also to eliminate false-positive genes because random genes (such as false positives) are much less likely to connect to pathways than genes that are changed due to shifts in biological processes and biochemical pathways. Confirmation of genes by in situ hybridization and RT-PCR. We used RT-PCR and in situ hybridization as alternative approaches to evaluate and confirm gene expression in heart tissue. RT-PCR was conducted on total RNA extracted from cardiac tissue using Trizol Reagent (Invitrogen, Carlsbad, California) by methods described previously (28) . Gene-specific probes and primer sets were deduced using Universal ProbeLibrary Assay Design software (Roche Applied Science, Indianapolis, Indiana). In situ hybridization of sections (16 mm) fixed in 4% formaldehyde was conducted, as previously described (29) . ] i concentrations were determined in PBMCs and cardiomyocytes. An approximate doubling of these divalent cations was found at 1 week and did not change appreciably at 4 weeks of ALDOST. The magnitude of these changes was similar in both PBMCs and cardiomyocytes, albeit the absolute amount of cytosolic free Ca 2þ and Zn 2þ differs between these respective noncontractile and contractile cells (Table 1) . Oxidative stress and free radical-induced damage. An increase in intracellular [Ca 2þ ] i and intramitochondrial [Ca 2þ ] m stimulates the generation of H 2 O 2 by these organelles and consequent free radical-induced damage to lipids determined by increased levels of 8-isoprostane. Both PBMCs and mitochondria demonstrated a significant increase in H 2 O 2 generation at 1 week and with a further increase at 4 weeks of ALDOST and an increase in 8-isoprostane levels in both PBMCs and cardiomyocytes at 1 week and 4 weeks ( Table 2) .
Results

Intracellular
Gene expression profiles of the heart. We examined gene expression in heart tissue collected after 1 and 4 weeks of ALDOST and compared them with controls, using the Affymetrix Rat 230 2.0 expression array. Of the 31,099 probe sets on this array, 22,538 showed expression (present or marginal signal) in at least 1 of the 15 samples. We conducted ANOVA on the 22,538 probe sets to define genes that were affected by ALDOST (BenjaminiHochberg multiple test correction p 0.01) and identified 83 probe sets (Online Table 1 ). Hierarchical clustering indicated that each of these probe sets belonged to 1 of 2 expression patterns that either quenched or amplified in response to ALDOST (Fig. 1A) . However, it must be emphasized that the effect of ALDOST was already evident at preclinical 1 week.
The list of probe sets clearly affected by ALDOST was systematically mined for pathway connectivity using the Ingenuity database. The 83 probe sets represented 52 different genes for which the Ingenuity knowledge database had information to connect these genes to other genes in the database. Six of these genes, however, could not be connected to any other genes from the list of 52. The remaining 46 genes were connected in 4 networks with 13, 13, 12, and 8 of these genes belonging to each cluster. The 3 networks with >10 ALDOST-associated genes in each were fused into a single network using the merge network function with the resulting network shown in Figure 1B . These 3 major networks were linked to pro-oxidant/ proinflammatory-related genes NFkB, p38 MAPK, and TGF-b 1 . Gene expression profiles in PBMCs. We analyzed gene expression in PBMCs collected from ALDOST in a manner similar to that described for heart tissue. We used the Affymetrix RAE 230A expression array and found that 10,352 of the 15,923 probe sets on this array showed expression (present or marginal signal) in at least 1 of the 15 samples. We conducted ANOVA on the 10,352 probe sets to define genes that were affected by ALDOST using Values are mean AE SD. *p < 0.001 ALDOST vs. controls; 6 in each group. yp < 0.05. Abbreviations as in Table 1 .
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PBMCs as Novel Biomarkers a more stringent p value of 0.001, but did not apply a multiple test correction to this dataset. This analysis revealed that 55 probe sets were affected by the treatment (Online Table 2 ). We conducted a hierarchical clustering analysis of these 55 probe sets with the resulting gene tree shown in Figure 2A . The genes that belong to subclusters JACC: Heart Failure Vol. 1, No. 6, 2013
PBMCs as Novel Biomarkers with a clear pattern of decrease or increase in response to ALDOST are noted with a solid bar to the right of the gene tree. It should be noted that for all of these 42 genes whose expression was affected by ALDOST, the responses appeared greater at 1 week, long before cardiac pathology was found. The list of 42 probe sets, consisting of 27 different genes, clearly affected by ALDOST was mined for pathway connectivity using the Ingenuity database. Four of these genes could not be connected to any other genes from the list of 27. The remaining 23 genes were connected in 2 networks (with 12 and 11 genes in each) that were fused into a single network shown in Figure 2B . As in heart tissue, the network in PBMCs was linked to pro-oxidant/ proinflammatory-related genes NFkB, p38 MAPK, and TGF-b 1 . Gene expression by in situ hybridization and RT-PCR. To confirm the central role of TGF-b 1 in the genesis of remodeling observed at sites of fibrosis, we conducted in situ hybridization on coronal sections and RT-PCR analysis on RNA extracted from heart tissue. The results are shown in Figure 3 . In situ hybridization demonstrated a more intense signal for this cytokine in hearts of rats receiving ALDOST (Fig. 3B ) compared with tissue harvested from controls (Fig. 3A) . Further confirmation of this response was demonstrated by RT-PCR with a significant upregulation of TGF-b 1 in rats receiving ALDOST (Fig. 3C ).
Discussion
We hypothesized that marked cation dyshomeostasis and oxidative stress induced by ALDOST will affect both the myocardium and PBMCs and reveal similar biochemical changes and gene expression profiles at preclinical and pathological stages of cardiac remodeling in HHD. Our findings imply that the PBMC transcriptome can serve as a surrogate marker of pathological events in the heart. In situ hybridization with a transforming growth factor b 1 (TGF-b 1 )-specific probe on coronal sections of hearts obtained from rats serving as controls (A) and at 4 weeks aldosterone/salt treatment (ALDOST) (B). High-density TGF-b 1 expression in heart tissue is seen as the yellow-red areas corresponding to sites of fibrosis. At 4 weeks ALDOST, tissue TGF-b 1 was also evaluated using reverse-transcription polymerase chain reaction (C). *p < 0.05 by the Student t test.
Gerling et al. To gain more specific and target tissue-based biomarkers, Affymetrix expression arrays were used to evaluate the comprehensive gene expression patterns in heart tissue and PBMCs. Hierarchical clustering of genes eliciting a statistically significant differential expression revealed that almost all of the effects of ALDOST were already present at 1 week, and at 4 weeks, their expression remained, by and large, similar to that at 1 week.
To better illustrate the underlying processes of gene expression abnormalities induced by ALDOST, we subjected the lists of differentially expressed genes to network analysis. The network created by genes whose expression in heart tissue is significantly affected by ALDOST was dominated by genes involved in oxidative stress, inflammation, and cell growth, as well as a large number of connections to other genes related to growth factors, such as insulin, vascular endothelial growth factor, tumor necrosis factor a, and platelet-derived growth factor.
Using cardiac tissue and PBMC transcriptomes, we unraveled a similar signal-transducer-effector pathway to be involved that includes the 3 major signaling cascades: p38 mitogen-activated protein kinase, a stress responsive protein; nuclear factor kB (NFkB), a downstream redox-sensitive transcription factor and its proinflammatory target genes (e.g., ICAM-1, MCP-1, and TNF-a); and tissue repair via transforming growth factor b 1 , a fibrogenic cytokine.
However, we would not speculate on complete concordance of gene expression profiles between noncontractile immune cells and contractile cardiomyocytes during stressor states. We recently reported on similarities and differences in gene profiling between 2 contractile tissues, heart and muscle, in response to 4 weeks of ALDOST (39) .
As demonstrated by in situ hybridization to detect and localize messenger ribonucleic acid expression and immunohistochemical labeling of protein in our previous studies (18) , the network created by the PBMC transcriptome was significantly affected by ALDOST and dominated by genes involved in oxidative stress, inflammation, and cell growth and death. Central to these networks, together with a large number of connections to other genes, we found genes integral to the process of inflammation, such as IL-6, NFkB, and p38 MAPK, and growth factors, such as hepatocyte growth factor and transforming growth factor b 1 to be involved in the preclinical stage. Furthermore, the network contains a number of caspases and apoptosis-inhibiting genes, such as STAT3. Using the PBMC transcriptome as biomarkers in patients with decompensated heart failure, transcripts related to inflammation and oxidative stress were expressed in abundance, including NFkB, MCP-1, tumor necrosis factor a and transforming growth factor b 1 (3) (4) (5) (6) (7) (8) (9) . It was recently suggested that PBMC gene expression profiling may identify the preclinical stage of systolic heart failure (21), and the up-regulated PBMC gene network may provide a molecular signature distinguishing patients with heart failure from healthy controls (8) .
Our investigation of gene expression profiles in heart tissue and PBMCs indicated that although there are similarities in the molecular pathways activated by ALDOST, differences also exist. These differential expression patterns are perhaps due to the fact that the 2 processes are played out somewhat differently in these 2 tissues. PBMCs are the effectors of inflammation where the coronary vasculature is one of their targets. Within the networks created from the 2 different tissues, we identified 3 central genes that are common: p38 MAPK, NFkB, and TGF-b 1 . We previously showed that NFkB plays a central role in the proinflammatory cardiac phenotype seen at week 4 ALDOST, together with the proinflammatory genes it regulates (18) . In those studies, NFkB and 3-nitrotyrosine, an index of oxidative damage, were shown to be amplified in the heart by immunohistochemistry. Both NFkB and p38 mitogenactivated protein kinase are redox sensitive and activated by reactive oxygen species. Cotreatment with either N-acetylcysteine, an antioxidant, or a Zn 2þ ionophore attenuated these responses, implicating the relevance of antioxidant defenses (18) . Study limitations. We did not obtain serial blood samples from the same animal at weeks 1 and 4 of ALDOST, nor did we investigate all transcriptome findings in heart tissue with RT-PCR methodology. We did, however, confirm the gene chip data and central Ingenuity pathway analysis with our earlier interrogation of mRNA expression and upregulated proteins using in situ hybridization and immunohistochemistry, respectively (18) . Furthermore, the use of pathway analysis can eliminate false-positive genes because those genes are much less likely to connect in pathways than true positives affected by changes in biological processes. Finally, we did not conduct a prediction analysis, as suggested by Heidecker et al. (40) . ] i occur, together with the induction of oxidative stress, in rats during ALDOST. There is a similarity in the transcriptome of PBMCs and heart tissue that is first evident during the preclinical stage and persists into the pathological stage of chronic aldosteronism with HHD. These findings raise the prospect that PBMCs are capable of revealing the early diagnostic signs as a noninvasive biomarker expression profile predictive of cardiac remodeling and thereby has the potential to serve as a novel sentinel and useful molecular signature in monitoring cardioprotection and management strategies in human HHD. 
Conclusions
